| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1479064 |
Orphenadrine Related Compound F (50 mg) (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate) |
19804-27-4 |
|
| 2922199695 |
|
|
|
| USP-1479202 |
Gamma-Oryzanol (50 mg) |
11042-64-1 |
UN2811 |
| USP-1479304 |
Oseltamivir Phosphate (200 mg) |
204255-11-8 |
|
| 2924299500 |
|
|
|
| USP-1479315 |
Oseltamivir Related Compound A (10 mg) ((3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate) |
N/A |
|
| 2924299500 |
|
|
|
| USP-1481000 |
Oxacillin Sodium (200 mg) |
7240-38-2 |
|
| 2941106000 |
|
|
|
| USP-1481044 |
Oxacillin Related Compound C (15 mg) (5-Methyl-3-phenylisoxazole-4-carboxylic acid) |
1136-45-4 |
|
| 2934990005 |
|
|
|
| USP-1481204 |
Oxaliplatin (125 mg) |
61825-94-3 |
UN3467 |
| USP-1481215 |
Oxaliplatin Related Compound A (100 mg) (Ethanedioic acid, dihydrate) |
6153-56-6 |
|
| 2917110000 |
|
|
|
| USP-1481226 |
Oxaliplatin Related Compound B (15 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N’) dinitratoplatinum(II)) |
66900-68-3 |
UN3467 |
| USP-1481237 |
Oxaliplatin Related Compound C (20 mg) ([1R-trans-(1,2-cyclohexanediamine-N,N’)]-trans-dihydroxido-[oxalato(2-)-O,O’]platinum(IV)) |
111321-67-6 |
UN3467 |
| USP-1481248 |
Oxaliplatin Related Compound D (10 mg) (cis-[(1S,2S)-1,2-cyclohexanediamine-N,N’][oxalato(2-)-O,O’]platinum) |
61758-77-8 |
UN3467 |
| USP-1481260 |
Oxaliplatin Related Compound F (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N’) diiodidoplatinum(II)) |
66845-32-7 |
UN3467 |
| USP-1481306 |
Oxaliplatin System Suitability (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N’) dichloridoplatinum(II)) |
61848-66-6 |
UN3467 |
| USP-1482207 |
Oxaprozin (200 mg) |
21256-18-8 |
|
| 2934990005 |
|
|
|
| USP-1483017 |
Oxazepam Related Compound A (15 mg) (7-chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione) |
19554-95-1 |
|
| 2933910000 |
|
|
|
| USP-1483028 |
Oxazepam Related Compound B (15 mg) (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate) |
1824-74-4 |
|
| 2933998350 |
|
|
|
| USP-1483039 |
Oxazepam Related Compound C (15 mg) (6-chloro-4-phenylquinazoline-2-carbaldehyde) |
5958/5/4 |
|
| 2933999552 |
|
|
|
| USP-1483152 |
Oxcarbazepine (100 mg) |
28721-07-5 |
|
| 2933996500 |
|
|
|
| USP-1483163 |
Oxcarbazepine Related Compound A (10 mg) (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1483174 |
Oxcarbazepine Related Compound B (10 mg) (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1483185 |
Oxcarbazepine Related Compound C (10 mg) (Acridin-9(10H)-one) |
578-95-0 |
|
| 2933998350 |
|
|
|
| USP-1483200 |
Oxcarbazepine Related Compound E (10 mg) (10(11H)-Oxo-5H-dibenz[b,f]azepine) |
21737-58-6 |
|
| 2933998350 |
|
|
|
| USP-1483301 |
Oxfendazole (200 mg) |
53716-50-0 |
|
| 2933997500 |
|
|
|
| USP-1483425 |
Oxiconazole Nitrate (200 mg) |
64211-46-7 |
|
| 2933290000 |
|
|
|
| USP-1483436 |
Oxiconazole Related Compound A (20 mg) (2′,4′-Dichloro-2-imidazol-1-ylacetophenone (E)-[O-(2,4-dichlorobenzyl)oxime]) |
76472-50-9 |
|
| 2933290000 |
|
|
|
| USP-1483447 |
Oxiconazole Related Compound B (20 mg) ((Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime) |
64211-06-9 |
|
| 2933290000 |
|
|
|
| USP-1483458 |
Oxiconazole Related Compound C (20 mg) (1-(2,4-Dichlorophenyl)-2-(1H -imidazol-1-yl)ethan-1-one hydrochloride) |
98164-08-0 |
|
| 2933290000 |
|
|
|
| USP-1483469 |
Oxiconazole Related Compound D (50 mg) ((2,4-Dichlorophenyl)methanol) |
1777-82-8 |
|
| 2906290000 |
|
|
|
| USP-1483470 |
Oxiconazole Related Compound E (100 mg) (2,4-Dichlorobenzyl chloride) |
94-99-5 |
UN3265 |
| USP-1483505 |
Oxprenolol Hydrochloride (200 mg) |
6452-73-9 |
UN2811 |
| USP-1484009 |
Oxtriphylline (500 mg) |
4499-40-5 |
|
| 2939590000 |
|
|
|
| USP-1485001 |
Oxybenzone (150 mg) |
131-57-7 |
|
| 2914500000 |
|
|
|
| USP-1485103 |
Oxybutynin Chloride (200 mg) |
1508-65-2 |
|
| 2922190900 |
|
|
|
| USP-1086957 |
Calcium Lignosulfonate (40-65) (2 g) |
8061-52-7 |
|
| 3913908000 |
|
|
|
| USP-1086979 |
Calcium Magnesium Citrate (200 mg) |
1370511-52-6 |
|
| 2918150000 |
|
|
|
| USP-1087009 |
Calcium Pantothenate (300 mg) (Vitamin B5) |
137-08-6 |
|
| 2936240100 |
|
|
|
| USP-1087031 |
Tribasic Calcium Phosphate (1 g) (AS) |
12167-74-7 |
|
| 2835260000 |
|
|
|
| USP-1087053 |
Calcium Propionate (100 mg) |
4075-81-4 |
|
| 2915503000 |
|
|
|
| USP-1087202 |
Calcium Saccharate (200 mg) |
5793-89-5 |
|
| 2918195000 |
|
|
|
| USP-1087360 |
Calcium Succinate (200 mg) |
159389-75-0 |
|
| 2917197055 |
|
|
|
| USP-1087450 |
Calcium Undecylenate (200 mg) |
1322-14-1 |
|
| 2916196000 |
|
|
|
| USP-1087472 |
Calycosin (50 mg) (7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one) |
20575-57-9 |
|
| 2932996560 |
|
|
|
| USP-1087483 |
Calycosin 7-O-beta-D-Glucopyranoside (50 mg) (3-(3-Hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside) |
20633-67-4 |
|
| 2932996560 |
|
|
|
| USP-1087508 |
Camphor (1 g) |
464-49-3 |
UN2717 |
| USP-1087520 |
D-camphor sulfonic acid (100 mg) |
3144-16-9 |
UN3261 |
| USP-1087701 |
Candelilla Wax (250 mg) |
8006-44-8 |
|
| 1521100000 |
|
|
|
| USP-1087803 |
Candesartan Cilexetil (100 mg) |
145040-37-5 |
|
| 2933995300 |
|
|
|
| USP-1087814 |
Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1087825 |
Candesartan Cilexetil Related Compound B (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate) |
869631-11-8 |
|
| 2933998350 |
|
|
|
| USP-1087847 |
Candesartan Cilexetil Related Compound D (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2′-(2-ethyl-2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1087869 |
Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2′-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate) |
914613-36-8 |
|
| 2933998350 |
|
|
|
| USP-1087870 |
Candesartan Cilexetil Related Compound G (10 mg) (1-{[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid) |
139481-59-7 |
|
| 2933998350 |
|
|
|
| USP-1089149 |
Cannabidiol (30 mg) |
13956-29-1 |
|
| 2907299000 |
|
|
|
| USP-1090706 |
Capecitabine (200 mg) |
154361-50-9 |
|
| 2934990005 |
|
|
|
| USP-1090717 |
Capecitabine Related Compound A (15 mg) (5′-deoxy-5-fluorocytidine) |
66335-38-4 |
|
| 2934990005 |
|
|
|
| USP-1090728 |
Capecitabine Related Compound B (20 mg) (5′-deoxy-5-fluorouridine) |
3094/9/5 |
|
| 2934990005 |
|
|
|
| USP-1090739 |
Capecitabine Related Compound C (10 mg) (2′,3′-O-carbonyl-5′-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine) (需冷链运输) |
921769-65-5 |
|
| 2934990005 |
|
|
|
| USP-1091006 |
Capreomycin Sulfate (250 mg) |
1405-37-4 |
|
| 2941901010 |
|
|
|
| USP-1091039 |
Caprolactam (1 g) |
105-60-2 |
|
| 2933710000 |
|
|
|
| USP-1091040 |
Caprylic Acid (300 mg) |
124-07-2 |
UN3265 |
| USP-1091108 |
Capsaicin (100 mg) |
404-86-4 |
UN1544 |
| USP-1091200 |
Captopril (200 mg) |
62571-86-2 |
|
| 2933999552 |
|
|
|
| USP-1091221 |
Captopril Disulfide (100 mg) |
64806-05-9 |
|
| 2933999552 |
|
|
|
| USP-1092009 |
Carbachol (200 mg) |
51-83-2 |
UN2811 |
| USP-1093001 |
Carbamazepine (100 mg) |
298-46-4 |
UN3077 |
| USP-1093012 |
Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarbamazepine) |
3564-73-6 |
|
| 2933998350 |
|
|
|
| USP-1093023 |
Carbamazepine Related Compound B (50 mg) (5H-Dibenz[b,f]azepine) |
256-96-2 |
|
| 2933998350 |
|
|
|
| USP-1095506 |
Carbidopa (400 mg) |
38821-49-7 |
|
| 2928002500 |
|
|
|
| USP-1443599 |
Midazolam CIV (300 mg) |
59467-70-8 |
UN2811 |
| USP-1443602 |
Midazolam Hydrochloride CIV (200 mg) |
59467-96-8 |
|
| 2933910000 |
|
|
|
| USP-1445404 |
Modafinil CIV (200 mg) |
68693-11-8 |
|
| 2930902000 |
|
|
|
| USP-1447002 |
Morphine Monohydrate CII (50 mg) (AS) |
6009-81-0 |
UN2811 |
| USP-1448005 |
Morphine Sulfate CII (500 mg) |
6211-15-0 |
|
| 2939110000 |
|
|
|
| USP-1448016 |
Morphine Related Compound A CI (20 mg) (7,8-Didehydro-4,5alpha-epoxy-17-methylmorphinan-3,6alpha-diol, N-oxide) |
639-46-3 |
|
| 2939190000 |
|
|
|
| USP-1448027 |
Morphine Related Compound B CII (20 mg) (2,2′-Bimorphine trihydrate) |
6472-73-7 |
|
| 2939190000 |
|
|
|
| USP-1452002 |
Nalorphine Hydrochloride CIII (250 mg) |
57-29-4 |
|
| 2939190000 |
|
|
|
| USP-1453049 |
Naloxone Related Compound D CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-(prop-2-enyl)morphinan-7-ene-6-one) |
26451-92-3 |
|
| 2939190000 |
|
|
|
| USP-1453526 |
Naltrexone Related Compound A CII (30 mg) (N-(3-butenyl)-noroxymorphone Hydrochloride) |
N/A |
|
| 2939190000 |
|
|
|
| USP-1454008 |
Nandrolone CIII (50 mg) |
434-22-0 |
|
| 2937290000 |
|
|
|
| USP-1455000 |
Nandrolone Decanoate CIII (250 mg) (需冷链运输) |
360-70-3 |
|
| 2937290000 |
|
|
|
| USP-1468400 |
Nordazepam CIV (50 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one) |
1088-11-5 |
|
| 2933910000 |
|
|
|
| USP-1470026 |
Norethindrone Related Compound B CIII (30 mg) (Estr-4-ene-3,17-dione) |
734-32-7 |
|
| 2914299000 |
|
|
|
| USP-1473002 |
Noroxymorphone Hydrochloride CII (50 mg) (4,5alpha-Epoxy-3,14-dihydroxymorphinan-6-one hydrochloride) |
52446-24-9 |
|
| 2939190000 |
|
|
|
| USP-1482003 |
Oxandrolone CIII (50 mg) |
53-39-4 |
|
| 2937290000 |
|
|
|
| USP-1482014 |
Oxandrolone Related Compound A CIII (20 mg) (17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one) |
1391052-43-9 |
|
| 2932206000 |
|
|
|
| USP-1482025 |
Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androsta-3-one) |
4424-45-7 |
|
| 2932206000 |
|
|
|
| USP-1482036 |
Oxandrolone Related Compound C CIII (20 mg) (17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one) |
N/A |
|
| 2932206000 |
|
|
|
| USP-1483006 |
Oxazepam CIV (200 mg) |
604-75-1 |
|
| 2933910000 |
|
|
|
| USP-1485191 |
Oxycodone CII (200 mg) |
76-42-6 |
|
| 2939110000 |
|
|
|
| USP-1485216 |
Oxycodone Related Compound A CII (10 mg) (14-hydroxycodeinone) (需冷链运输) |
508-54-3 |
|
| 2939190000 |
|
|
|
| USP-1485227 |
Oxycodone Related Compound B CII (15 mg) (oxycodone N-oxide) |
71539-52-1 |
|
| 2939190000 |
|
|
|
| USP-1485238 |
Oxycodone Related Compound C CII (15 mg) (codeinone) |
467-13-0 |
UN2811 |
| USP-1487007 |
Oxymetholone CIII (200 mg) |
434-07-1 |
|
| 2937290000 |
|
|
|
| USP-1488000 |
Oxymorphone CII (300 mg) |
76-41-5 |
UN2811 |
| USP-1488019 |
Oxymorphone Related Compound A CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one N-oxide) |
71360-37-7 |
|
| 2939110000 |
|
|
|
| USP-1505007 |
Pentazocine CIV (500 mg) |
359-83-1 |
|
| 2933330100 |
|
|
|
| USP-1516003 |
Phencyclidine Hydrochloride CII (25 mg) (AS) |
956-90-1 |
UN2811 |
| USP-1516502 |
Phendimetrazine Tartrate CIII (350 mg) |
50-58-8 |
UN2811 |
| USP-1524001 |
Phenobarbital CIV (200 mg) |
1950/6/6 |
UN2811 |
| USP-1528501 |
Phentermine Hydrochloride CIV (200 mg) |
1197-21-3 |
UN2811 |
| USP-1554501 |
Prazepam CIV (500 mg) |
2955-38-6 |
|
| 2933910000 |
|
|
|
| USP-1102963 |
Cetirizine Related Compound G (50 mg) (2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethanol dihydrochloride) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1102974 |
Cetrimonium Bromide (1 g) |
57-09-0 |
|
| 2923900100 |
|
|
|
| USP-1103003 |
Cetyl Alcohol (100 mg) |
36653-82-4 |
|
| 2905170000 |
|
|
|
| USP-1103105 |
Cetyl Palmitate (50 mg) |
540-10-3 |
|
| 2915700100 |
|
|
|
| USP-1104006 |
Cetylpyridinium Chloride (500 mg) |
6004-24-6 |
UN2811 |
| USP-1104210 |
Cevimeline Hydrochloride (100 mg) |
153504-70-2 |
UN2811 |
| USP-1104265 |
Cevimeline trans-Isomer (15 mg) ((2RS,2’SR)-2′-Methyl-4-azaspiro{bicyclo[2.2.2]octane-2,5′-[1,3]oxathiolane} hydrochloride hemihydrate) |
1462862-74-3 |
UN2811 |
| USP-1105009 |
Powdered Chaste Tree Extract (1.5 g) |
91722-47-3 |
|
| 1302190200 |
|
|
|
| USP-1105155 |
Chebulagic Acid (25 mg) |
23094-71-5 |
|
| 2938900000 |
|
|
|
| USP-1105315 |
Chicoric Acid (20 mg) |
70831-56-0 |
|
| 2918290000 |
|
|
|
| USP-1105417 |
Powdered Chinese Salvia Extract (1 g) |
115939-25-8 |
|
| 1302190200 |
|
|
|
| USP-1105450 |
D-chiro-Inositol (150 mg) |
643-12-9 |
|
| 2906130000 |
|
|
|
| USP-1105508 |
Chitosan (500 mg) |
9012-76-4 |
|
| 3913901000 |
|
|
|
| USP-1106001 |
Chlorambucil (125 mg) |
305-03-3 |
UN2811 |
| USP-1106078 |
Chlorambucil System Suitability Mixture (25 mg) (A mixture containing 4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid and a small amount of 4-[m-[Bis(2-chloroethyl)amino]phenyl]butyric acid) |
N/A |
UN2811 |
| USP-1107004 |
Chloramphenicol (200 mg) |
56-75-7 |
|
| 2941400000 |
|
|
|
| USP-1107300 |
Chloramphenicol Palmitate (200 mg) |
530-43-8 |
|
| 2941400000 |
|
|
|
| USP-1107401 |
Chloramphenicol Palmitate Nonpolymorph A (200 mg) |
530-43-8 |
|
| 2941400000 |
|
|
|
| USP-1107503 |
Chloramphenicol Palmitate Polymorph A (100 mg) |
530-43-8 |
|
| 2941400000 |
|
|
|
| USP-1110020 |
Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) |
963-39-3 |
|
| 2933996100 |
|
|
|
| USP-1111001 |
Chlorhexidine (200 mg) |
55-56-1 |
UN3077 |
| USP-1111012 |
Chlorhexidine System Suitability Mixture (50 mg) |
NA |
UN3077 |
| USP-1111103 |
Chlorhexidine Acetate (200 mg) |
56-95-1 |
UN2811 |
| USP-1111908 |
P-Chloroaniline (200 mg) |
106-47-8 |
UN2018 |
| USP-1112299 |
3-Chlorobenzoic Acid (25 mg) |
535-80-8 |
|
| 2916399000 |
|
|
|
| USP-1112311 |
Chlorobenzhydryl Piperazine (75 mg) |
300543-56-0 |
|
| 2933599550 |
|
|
|
| USP-1112423 |
Indomethacin Related Compound B (25 mg) (4-chlorobenzoic acid) |
1974/11/3 |
|
| 2916399000 |
|
|
|
| USP-1112467 |
4-Chlorobenzophenone (30 mg) (4-Chlorobenzophenone) |
134-85-0 |
|
| 2914790000 |
|
|
|
| USP-1112503 |
Chlorobutanol (200 mg) |
6001-64-5 |
|
| 2905590000 |
|
|
|
| USP-1115545 |
Chlorogenic Acid (50 mg) |
327-97-9 |
|
| 2918290000 |
|
|
|
| USP-1115556 |
beta-Chlorogenin (20 mg) |
N/A |
|
| 2932999000 |
|
|
|
| USP-1116774 |
Chlorophyll A (15 mg) |
479-61-8 |
|
| 3203000000 |
|
|
|
| USP-1117008 |
Chloroprocaine Hydrochloride (200 mg) |
3858-89-7 |
|
| 2922492050 |
|
|
|
| USP-1117110 |
Chloropropyl Vanillin (25 mg) (4-(3-Chloropropoxy)-3-methoxybenzaldehyde) |
151719-92-5 |
|
| 2913000000 |
|
|
|
| USP-1118000 |
Chloroquine Phosphate (500 mg) |
50-63-5 |
|
| 2933492250 |
|
|
|
| USP-1118328 |
Chloroquine Related Compound A (15 mg) (4,7-dichloroquinoline) |
86-98-6 |
|
| 2933497050 |
|
|
|
| USP-1118350 |
Chloroquine Related Compound D (15 mg) (7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline) |
1476-52-4 |
|
| 2933497050 |
|
|
|
| USP-1118361 |
Chloroquine Related Compound E (10 mg) (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate) |
N/A |
|
| 2933497050 |
|
|
|
| USP-1118394 |
Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate) |
N/A |
|
| 2933497050 |
|
|
|
| USP-1119309 |
Chlorthalidone Related Compound A (10 mg) (4′-Chloro-3′-sulfamoyl-2-benzophenone Carboxylic Acid) |
5270-74-6 |
|
| 2935909550 |
|
|
|
| USP-1121005 |
Chlorothiazide (200 mg) |
58-94-6 |
|
| 2935904000 |
|
|
|
| USP-1121038 |
8-Chlorotheophylline (200 mg) |
85-18-7 |
|
| 2939590000 |
|
|
|
| USP-1122700 |
Chloroxylenol (125 mg) |
88-04-0 |
UN3077 |
| USP-1122722 |
Chloroxylenol Related Compound A (25 mg) (2-chloro-3,5-dimethylphenol) |
5538-41-0 |
|
| 2908199000 |
|
|
|
| USP-1123000 |
Chlorpheniramine Maleate (125 mg) |
113-92-8 |
UN2811 |
| USP-1123135 |
Chlorpheniramine Related Compound B (25 mg) (di(pyridin-2-yl)amine) |
1202-34-2 |
UN1544 |
| USP-1123146 |
Chlorpheniramine Related Compound C (10 mg) (3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine maleate) |
22630-25-7 |
|
| 2933399095 |
|
|
|
| USP-1125006 |
Chlorpromazine Hydrochloride (200 mg) |
69-09-0 |
UN2811 |
| USP-1126009 |
Chlorpropamide (200 mg) |
94-20-2 |
|
| 2935904000 |
|
|
|
| USP-1129007 |
Chlortetracycline Hydrochloride (200 mg) |
64-72-2 |
|
| 2941300000 |
|
|
|
| USP-1130006 |
Chlorthalidone (200 mg) |
77-36-1 |
|
| 2935904000 |
|
|
|
| USP-1130505 |
Chlorzoxazone (350 mg) |
95-25-0 |
|
| 2934990005 |
|
|
|
| USP-1130527 |
Chlorzoxazone Related Compound A (50 mg) (2-Amino-4-chlorophenol) |
95-85-2 |
UN2673 |
| USP-1131858 |
Cholestanol (200 mg) |
80-97-7 |
|
| 2906130000 |
|
|
|
| USP-1131960 |
Cholesterol (125 mg) |
57-88-5 |
|
| 2906130000 |
|
|
|
| USP-1132001 |
Cholesteryl Caprylate (200 mg) |
1182-42-9 |
|
| 2915900000 |
|
|
|
| USP-1133004 |
Cholestyramine Resin (500 mg) |
11041-12-6 |
|
| 3914002000 |
|
|
|
| USP-1133503 |
Cholic Acid (200 mg) |
81-25-4 |
|
| 2918195000 |
|
|
|
| USP-1133536 |
Choline Bitartrate (200 mg) |
87-67-2 |
|
| 2923100000 |
|
|
|
| USP-1133547 |
Choline Chloride (500 mg) |
67-48-1 |
|
| 2923100000 |
|
|
|
| USP-1133558 |
Choline Fenofibrate (50 mg) (2-Hydroxy-N,N,N-trimethylethanaminium 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate) |
856676-23-8 |
|
| 2923100000 |
|
|
|
| USP-1133580 |
Oversulfated Chondroitin Sulfate (10 mg) |
N/A |
|
| 3913908000 |
|
|
|
| USP-1133591 |
Choline Citrate (500 mg) |
77-91-8 |
|
| 2923100000 |
|
|
|
| USP-1133616 |
Choline Related Compound A (200 mg) ([2-(Hydroxyethoxy)ethyl]trimethylammonium iodide) |
41830-55-1 |
|
| 2923900100 |
|
|
|
